This website uses cookies to enhance the user experience.
B

BIOFEED AS916 587 821

Research
Limited company
Jonsvannsveien 140 7050 TRONDHEIM, Norge

BIOFEED AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
9 years
since Jan 19, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
1,330
1 share class
Total number of shareholders
5
companies

Financials

Total operating income 2023
2,645
NOK
Annual total result 2023
-139,356
NOK
Total equity 2023
88,631
NOK
Last update: Oct 2, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
21.65 %
indirectly

Board

NameRoleShares
Chairman
21.65 %
indirectly
Board Member
21.65 %
indirectly
Board Member
21.65 %
indirectly
Board Member
13.38 %
indirectly
Board Member
21.65 %
indirectly

Others

NameRoleShares
Auditor-

Top 10 individual shareholders

NameRoleShares
Board Member
21.65 %
indirectly
Board Member
21.65 %
indirectly
Managing Director/CEO, Chairman
21.65 %
indirectly
Board Member
21.65 %
indirectly
Board Member
13.38 %
indirectly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
K
KTEO AS
Ordinary shares
288
21.65 %
P
PCL AS
Ordinary shares
288
21.65 %
K
KGL AS
Ordinary shares
288
21.65 %
T
TEL AS
Ordinary shares
288
21.65 %
C
COOL FOODS AS
Ordinary shares
178
13.38 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
2,645
0
23,718
Annual Total Result
-139,356
-197,499
-1,171,907
Total assets
90,471
236,163
491,221
Total liabilities
1,840
8,176
65,736
Total equity
88,631
227,986
425,485

P&L

Year202320222021
Total operating income
2,645
0
23,718
Total operating costs
117,937
172,540
1,170,819
Operating result
-115,292
-172,540
-1,147,101
Financial income/costs
-24,064
-24,959
-24,806
Profit before tax
-139,356
-197,499
-1,171,907
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-139,356
-197,499
-1,171,907

Balance overview

Year202320222021
Total fixed assets
0
2,856
6,956
Total current assets
90,471
233,307
484,265
Total assets
90,471
236,163
491,221
Short term debt
1,840
8,176
65,736
Long term debt
0
0
0
Total liabilities
1,840
8,176
65,736
Contributed capital
399,000
399,000
399,000
Retained earnings
-310,369
-171,014
26,485
Total equity
88,631
227,986
425,485
Total equity and liabilities
90,471
236,163
491,221

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology